Rising demand for Mounjaro in private clinics
GLP-1 prescribing continues to grow rapidly across the UK. Clinics offering weight-management, metabolic health, private GP, and aesthetic services are seeing a sharp rise in demand for Mounjaro.
However, scaling access to a Prescription-Only Medicine (POM) introduces operational, regulatory and governance requirements that most clinics are not built to handle internally.
This is where a compliant pharmacy partnership becomes essential.
PPRX, a GPhC-registered UK pharmacy, supplies hundreds of clinics nationwide with weight-loss pens and offers a full dispensing solution that allows clinics to scale safely without having to operate a pharmacy.
Visit us at:
https://www.pprx.co.uk
Why most clinics should not operate their own pharmacy
Dispensing prescription-only medicines requires specialised infrastructure, including:
• cold-chain storage and temperature monitoring
• dispensing and labelling standards
• controlled record-keeping and audit trails
• safety reporting systems
• compliant logistics for medicine delivery
Most clinics find that taking on these requirements:
• increases compliance exposure,
• diverts clinical resources, and
• complicates scaling.
Partnering with a pharmacy removes the operational burden while keeping prescribing fully independent.
Prescribing and dispensing Mounjaro must remain separate under UK law
A compliant Mounjaro supply pathway requires strict separation of roles.
Your clinic is responsible for:
• assessing suitability
• making an independent prescribing decision
• monitoring and follow-up
• patient outcomes
PPRX is responsible for:
• dispensing against valid prescriptions
• cold-chain handling and delivery
• patient information leaflets and correct labelling
• pharmacy records and audit trails
• safety reporting and recall readiness
This separation protects both patient safety and the clinic’s regulatory position.
Two scalable, compliant Mounjaro supply models supported by PPRX
Option 1: Direct-to-patient dispensing
This is the most popular, lowest-risk, and most scalable model.
How it works
- Clinic assesses and prescribes.
- Prescription is sent to PPRX.
- PPRX dispenses and supplies directly to the patient using temperature-controlled delivery.
Benefits
• no clinic storage required
• minimal operational complexity
• ideal for telehealth or multi-site clinics
• consistent pharmacy compliance built-in
Option 2: Clinic safekeeping under patient-specific controls (where permitted)
For clinics that need on-site access, PPRX can supply Mounjaro to the clinic for safekeeping under strict governance.
This requires:
• authority to hold POM stock
• SOPs for receipt, storage, and supply
• temperature monitoring logs
• traceable stock and dispensing records
• patient-specific prescribing only
PPRX helps clinics establish the required systems to remain audit-ready.
What PPRX needs to onboard your clinic for Mounjaro supply
To ensure safe and compliant supply, PPRX requests:
• clinic details and governance contact
• prescriber registration information
• confirmation of prescribing model
• preferred supply pathway
• storage and monitoring (if applying for clinic safekeeping)
Why clinics choose PPRX
Clinics partner with PPRX because we:
• are a GPhC-registered UK pharmacy
• supply hundreds of clinics nationwide
• specialise in GLP-1 dispensing workflows
• support scalable, compliant growth
• remove the operational burden from clinics
Contact PPRX to scale your clinic safely
If your clinic wants to expand Mounjaro services without taking on pharmacy responsibilities, PPRX can support you immediately.
Contact PPRX
Email: info@pprx.co.uk
WhatsApp: 07753 411111
Call: 0208 191 3034
Website: https://www.pprx.co.uk
Our pharmacy team will walk you through the safest and most compliant setup for your clinic.
